CRP/ albumin ratio can be a predictor of response to neoadjuvant chemoradiotherapy (CRT) in rectal cancer

dc.authorid0000-0001-9081-2405
dc.authorid0000-0001-9081-2405
dc.authorid0000-0002-4525-2020
dc.authorwosidseber, selcuk e/H-3327-2017
dc.authorwosidseber, selcuk/T-9539-2019
dc.authorwosidYOLCU, Ahmet/D-7451-2014
dc.contributor.authorYetişyiğit, Tarkan
dc.contributor.authorŞeber, Erdoğan Selçuk
dc.contributor.authorYolcu, Ahmet
dc.date.accessioned2022-05-11T14:40:56Z
dc.date.available2022-05-11T14:40:56Z
dc.date.issued2018
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Radyasyon Onkolojisi Ana Bilim Dalı
dc.descriptionESMO 20th World Congress on Gastrointestinal Cancer -- JUN 20-23, 2018 -- Barcelona, SPAIN
dc.description.abstract[No Abstract Available]
dc.description.sponsorshipEuropean Soc Med Oncol
dc.identifier.issn0923-7534
dc.identifier.issn1569-8041
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8980
dc.identifier.volume29
dc.identifier.wosWOS:000439970900333
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.institutionauthorYetişyiğit, Tarkan
dc.institutionauthorŞeber, Erdoğan Selçuk
dc.language.isoen
dc.publisherOxford Univ Press
dc.relation.ispartofAnnals of Oncology
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleCRP/ albumin ratio can be a predictor of response to neoadjuvant chemoradiotherapy (CRT) in rectal cancer
dc.typeConference Object

Dosyalar